Efficacy and safety of Y-spur in the treatment of male infertility disorders: an open-label clinical endpoint study

Authors

  • Ramesh Kannan Department of Pharmacology, PM Medical Centre, Walajapet, Tamil Nadu, India
  • Sakthibalan Murugesan Department of Pharmacology, DK Elite Health Care, Puducherry, India
  • Bijoy Deb Ki3 Private Limited, Chennai, Tamil Nadu, India
  • Gayathri Sivakumar Ki3 Private Limited, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20260883

Keywords:

Idiopathic male infertility, Infertility disorders, Oligospermia, Sperm morphology, Y-Spur

Abstract

Background: Idiopathic male infertility has a complex etiology that includes oxidative stress, hormonal dysregulation, genetics, lifestyle choices, and environmental pollutants that can affect spermatogenesis and lower the quality of sperm. A polyherbal formulation, Y-Spur Capsule contains various herbs that support reproductive health through different methods, improve semen quality, lowers oxidative stress, and increase sperm count, motility, morphology, and testosterone levels.

Methods: 30 males aged 18-45 years, diagnosed with idiopathic male infertility were enrolled in the study and followed for 9 months.

Results: Statistically significant and sustained improvements were observed over a period of 9 months compared to their baseline values in a.  semen volume (1.85±0.48 to 2.11±0.51), b. sperm concentration (11.6±1.96 to 17.7±2.37), c. total sperm count (14.4±3.06 to 22.93±2.32), d.  total motile sperm (14.1±2.92 to 50.13±6.27), e. normal sperm morphology (2.67±0.48 to 11.47±1.87) (p=0.0001).

Conclusions: The progressive improvement in sperm morphology and motility further supported the overall enhancement of sperm quality and reproductive potential and the safety evaluations confirmed that Y-Spur was well tolerated. In addition, Y-spur was well tolerated among the subjects and was considered safe when consumed over a period of 9 months.

References

Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reproduct Biol Endocrinol. 2015;13(1):37. DOI: https://doi.org/10.1186/s12958-015-0032-1

Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem. 2018;62:2-10. DOI: https://doi.org/10.1016/j.clinbiochem.2018.03.012

World Health Organization. WHO manual for the examination and processing of human semen, 6th edition. 2021. Available at: https://www.who.int/publications/i/item/9789240030787. Accessed 01 January 2026.

Krausz C. Male infertility: Pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metabol. 2011;25(2):271-85. DOI: https://doi.org/10.1016/j.beem.2010.08.006

Aitken RJ, Baker MA. Oxidative stress and male reproductive biology. Reproduct Fertil Development. 2004;16(5):581-8. DOI: https://doi.org/10.1071/RD03089

Tremellen K. Oxidative stress and male infertility-A clinical perspective. Human Reproduct Update. 2008;14(3):243-58. DOI: https://doi.org/10.1093/humupd/dmn004

Shukla KK, Mahdi AA, Rajender S. Oxidative stress and male infertility. Ind J Experimen Biol. 2009;47:963-8.

Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, et al. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril. 2010;94(3):989-96.

Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reproduct Biomedi Online. 2004;8(6):616-27. DOI: https://doi.org/10.1016/S1472-6483(10)61641-0

Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, et al. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril. 2010;94(3):989-96. DOI: https://doi.org/10.1016/j.fertnstert.2009.04.046

Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A. Clinical evaluation of the spermatogenic activity of the root extract of Ashwagandha (Withania somnifera) in oligospermic males: a pilot study. Evidence‐Based Complem Alternat Medi. 2013;2013(1):571420. DOI: https://doi.org/10.1155/2013/571420

Kumar S, Gupta RS. Effect of Leptadenia reticulata on male reproductive system of rats. Andrologia. 2006;38(5):183-7.

Saini M, Sharma S. Role of antioxidants in male fertility. J Human Reproduct Sci. 2015;8(1):19-23.

Singh N, Nath R. Herbal interventions in male infertility. As Pac J Reprod. 2014;3(1):12-8.

Pandey MP, Mahdi AA. Pippali (Piper longum) as a bioavailability enhancer: Implications for reproductive health. Phytother Res. 2014;28:1436-42.

Cooper TG, Noonan E, Von Eckardstein S, Auger J, Baker HG, Behre HM, et al. World Health Organization reference values for human semen characteristics. Human Reproduct Update. 2010;16(3):231-45. DOI: https://doi.org/10.1093/humupd/dmp048

Irvine DS. Epidemiology and aetiology of male infertility. Hum Reprod. 1998;13(Suppl 1):33-44. DOI: https://doi.org/10.1093/humrep/13.suppl_1.33

Jungwirth A, Diemer T, Dohle G, Giwercman A, Kopa Z, Krausz C, et al. EAU Guidelines on Male Infertility. Eur Urol. 2004;466162(512):555-8159.

Showell MG, Mackenzie‐Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2014;(12):CD007411. DOI: https://doi.org/10.1002/14651858.CD007411.pub3

Majzoub A, Agarwal A. Antioxidant therapy in idiopathic oligoasthenoteratozoospermia. World J Mens Health. 2018;36(2):77-85.

Guzick DS, Overstreet JW, Factor-Litvak P, Brazil CK, Nakajima ST, Coutifaris C, et al. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med. 2001;345(19):1388-93. DOI: https://doi.org/10.1056/NEJMoa003005

Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril. 1988;49(1):112-7. DOI: https://doi.org/10.1016/S0015-0282(16)59660-5

Menkveld R, Wong WY, Lombard CJ, van der Hoven L, Franken DR, Kruger TF, et al. Semen parameters, including WHO and strict criteria morphology, in a fertile and subfertile population: an attempt to identify cut-off values. Hum Reprod. 2001;16(6):1165-71. DOI: https://doi.org/10.1093/humrep/16.6.1165

Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. Reprod Biol Endocrinol. 2014;32(1):1. DOI: https://doi.org/10.5534/wjmh.2014.32.1.1

Sharma R, Harlev A, Agarwal A, Esteves SC. Cigarette smoking and semen quality: a new meta-analysis examining the effect of the 2010 WHO laboratory methods for the examination of human semen. Reprod Biol Endocrinol. 2016;70(4):635-45. DOI: https://doi.org/10.1016/j.eururo.2016.04.010

Agarwal A, Baskaran S, Parekh N, Cho CL, Henkel R, Vij S, et al. Male infertility. Andrologia. 2021;53(1):e13676. DOI: https://doi.org/10.1111/and.13577

Goodall H, Roberts AM. Differences in motility of human X- and Y-bearing spermatozoa. J Reproduct Fertil. 1976;48(2):433-6. DOI: https://doi.org/10.1530/jrf.0.0480433

Downloads

Published

2026-03-27

How to Cite

Kannan, R., Murugesan, S., Deb, B., & Sivakumar, G. (2026). Efficacy and safety of Y-spur in the treatment of male infertility disorders: an open-label clinical endpoint study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 15(4), 1259–1264. https://doi.org/10.18203/2320-1770.ijrcog20260883

Issue

Section

Original Research Articles